Sodium homeostasis and bone

Current Opinion in Nephrology and Hypertension

Volumn 23, Issue 4, 2014, Pages 370-376

  Hannon, Mark J ^a   Verbalis, Joseph G ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone; Falls; Fracture risk; Osteoporosis; Sodium balance; Vasopressin

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ARGIPRESSIN; ASCORBIC ACID; CHLORIDE; COPEPTIN; DESMOPRESSIN; ELECTROLYTE; PARATHYROID HORMONE; SODIUM; SODIUM ION;

BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE REMODELING; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL PH; EXTRACELLULAR FLUID; FRACTURE; FRAGILITY FRACTURE; GAIT DISORDER; HUMAN; HYPOGONADISM; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; NONHUMAN; OSMOLALITY; OSMOREGULATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM BALANCE; SODIUM DEFICIENCY; SODIUM METABOLISM; BLOOD; BONE; COMPLICATION; DEFICIENCY; FRACTURES, BONE; HOMEOSTASIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ARGININE VASOPRESSIN; BONE AND BONES; BONE DENSITY; EXTRACELLULAR FLUID; FRACTURES, BONE; HOMEOSTASIS; HUMANS; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; OSTEOCLASTS; OSTEOPOROSIS; SODIUM;

EID: 84902295490     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/01.mnh.0000447022.51722.f4     Document Type: Review

References (55)

1. Robertson GL, Aycinena P, Zerbe RL. Neurogenic disorders of osmoregulation. Am J Med 1982; 72:339-353.
2. Baylis PH, Thompson CJ. Osmoregulation of vasopressin secretion and thirst in health and disease. Clin Endocrinol (Oxf) 1988; 29:549-576.
3. Harrison HE, Darrow DC, Yannet H. The total electrolyte content of animals and its probable relation to the distribution of body water. J Biol Chem 1936; 113:515-529.
4. Kaltreider NL, Meneely GR, Allen JR, Bale WF. Determination of the volume of the extracellular fluid of the body with radioactive sodium. J Exp Med 1941; 74:569-590.
5. Forbes GB, Perley A. Estimation of total body sodium by isotopic dilution. I. Studies on young adults. J Clin Invest 1951; 30:558-565.
6. Bergstrom WH, Wallace WM. Bone as a sodium and potassium reservoir. J Clin Invest 1954; 33:867-873.
7. Gabriel S. Chemische Untersuchungen uber die Mineralstoffe der Knochen und Zahne. Ztschr f Physiol Chem 1894; 18:257.
8. Stern TN, Cole VV, Bass AC, Overman RR. Dynamic aspects of sodium metabolism in experimental adrenal insufficiency using radioactive sodium. Am J Physiol 1951; 164:437-449.
9. Shohl AT. Mineral metabolism. New York: Reinhold Publishing; 1939.
10. Bergstrom WH. The participation of bone in total body sodium metabolism in the rat. J Clin Invest 1955; 34 (Part 1):997-1004.
11. Nichols G Jr, Nichols N. Electrolyte equilibria in erythrocytes during diabetic acidosis. J Clin Invest 1953; 32:113-120.
12. Baran D, Hutchinson TA. The outcome of hyponatremia in a general hospital population. Clin Nephrol 1984; 22:72-76.
13. Flear CT, Gill GV, Burn J. Hyponatraemia: mechanisms and management. Lancet 1981; 2:26-31.
14. Hannon MJ, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. Eur J Endocrinol 2010; 162 (Suppl. 1):S5-S12.
15. Stelfox HT, Ahmed SB, Khandwala F, et al. The epidemiology of intensive care unit-Acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units. Crit Care 2008; 12:R162.
16. Zilberberg MD, Exuzides A, Spalding J, et al. Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study. BMC Pulm Med 2008; 8:16.
17. Gankam-Kengne F, Ayers C, Khera A, et al. Mild hyponatremia is associated with an increased risk of death in an ambulatory setting. Kidney Int 2013; 83:700-706.
18. Gill G, Huda B, Boyd A, et al. Characteristics and mortality of severe hyponatraemia - A hospital-based study. Clin Endocrinol (Oxf) 2006; 65:246-249.
19. Clayton JA, Le Jeune IR, Hall IP. Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome. QJM 2006; 99:505-511.
20. Corona G, Giuliani C, Parenti G, et al. Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-Analysis. PLoS One 2013; 8:e80451.
21. Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant 2006; 21:70-76.
22. Sajadieh A, Binici Z, Mouridsen MR, et al. Mild hyponatremia carries a poor prognosis in community subjects. Am J Med 2009; 122:679-686.
23. Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 2009; 122:857-865.
24. Renneboog B, Musch W, Vandemergel X, et al. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006; 119:71.e1-71.e8.
25. Gankam Kengne F, Andres C, Sattar L, et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 2008; 101:583-588.
26. Sandhu HS, Gilles E, DeVita MV, et al. Hyponatremia associated with largebone fracture in elderly patients. Int Urol Nephrol 2009; 41:733-737.
27. Kinsella S, Moran S, Sullivan MO, et al. Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol 2010; 5:275-280.
28. Tolouian R, Alhamad T, Farazmand M, Mulla ZD. The correlation of hip fracture and hyponatremia in the elderly. J Nephrol 2012; 25:789-793.
29. Hoorn EJ, Rivadeneira F, van Meurs JB, et al. Mild hyponatremia as a risk factor for fractures: the Rotterdam Study. J Bone Miner Res 2011; 26:1822-1828.
30. Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 1991; 88:303-309.
31. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330:613-622.
32. Barsony J, Manigrasso MB, Xu Q, et al. Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats. Age (Dordr) 2013; 35:271-288.
33. Verbalis JG, Barsony J, Sugimura Y, et al. Hyponatremia-induced osteoporosis. J Bone Miner Res 2010; 25:554-563.
34. Barsony J, Sugimura Y, Verbalis JG. Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss. J Biol Chem 2011; 286:10864-10875.
35. Zerbe RL, Robertson GL. Osmoregulation of thirst and vasopressin secretion in human subjects: effect of various solutes. Am J Physiol 1983; 244:E607-E614.
36. Lara LS, Satou R, Bourgeois CR, et al. The sodium-Activated sodium channel is expressed in the rat kidney thick ascending limb and collecting duct cells and is upregulated during high salt intake. Am J Physiol Renal Physiol 2012; 303:F105-F109.
37. Watanabe E, Hiyama TY, Kodama R, Noda M. NaX sodium channel is expressed in nonmyelinating Schwann cells and alveolar type II cells in mice. Neurosci Lett 2002; 330:109-113.
38. Frazier DT, Narahashi T. Tricaine (MS-222): effects on ionic conductances of squid axon membranes. Eur J Pharmacol 1975; 33:313-317.
39. Hedrick MS, Winmill RE. Excitatory and inhibitory effects of tricaine (MS-222) on fictive breathing in isolated bullfrog brain stem. Am J Physiol Regul Integr Comp Physiol 2003; 284:R405-R412.
40. Tseng AS, Beane WS, Lemire JM, et al. Induction of vertebrate regeneration by a transient sodium current. J Neurosci 2010; 30:13192-13200.
41. Johnson JA, Zehr JE, Moore WW. Effects of separate and concurrent osmotic and volume stimuli on plasma ADH in sheep. Am J Physiol 1970; 218:1273-1280.
42. Schrier RW, Fassett RG. Pathogenesis of sodium and water retention in cardiac failure. Ren Fail 1998; 20:773-781.
43. Cardenas A, Arroyo V. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites. Best Pract Res Clin Endocrinol Metab 2003; 17:607-622.
44. Tamma R, Sun L, Cuscito C, et al. Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia. Proc Natl Acad Sci USA 2013; 110:18644-18649.
45. Abe E, Marians RC, Yu W, et al. TSH is a negative regulator of skeletal remodeling. Cell 2003; 115:151-162.
46. Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell 2006; 125:247-260.
47. Zaidi M, Sun L, Robinson LJ, et al. ACTH protects against glucocorticoidinduced osteonecrosis of bone. Proc Natl Acad Sci USA 2010; 107:8782-8787.
48. Tamma R, Colaianni G, Zhu LL, et al. Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci USA 2009; 106:7149-7154.
49. Verbalis JG. Hyponatraemia. Ballieres Clin Endocrinol Metab 1989; 3:499-530.
50. Smith DM, McKenna K, Thompson CJ. Hyponatraemia. Clin Endocrinol (Oxf) 2000; 52:667-678.
51. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 2013; 126 (10 Suppl. 1):S1-S42.
52. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006; 52:112-119.
53. Morgenthaler NG, Struck J, Jochberger S, Dunser MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 2008; 19:43-49.
54. Balanescu S, Kopp P, Gaskill MB, et al. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar states. J Clin Endocrinol Metab 2011; 96:1046-1052.
55. Verbalis JG, Drutarosky MD. Adaptation to chronic hypoosmolality in rats. Kidney Int 1988; 34:351-360.